Our team introduced ferumoxytol‐enhanced MRI as a new imaging biomarker for CD47 mAb‐mediated changes in TAM quantities and phagocytic activity in mouse models of MNNG/HOS osteosarcomas. This evidence concerns the gene CD47 and osteosarcoma.